Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kala Bio Inc
(NQ:
KALA
)
5.850
-0.040 (-0.68%)
Streaming Delayed Price
Updated: 3:24 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Kala Bio Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
August 08, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA Stock Earnings: Kala Bio Beats EPS for Q2 2024
August 06, 2024
KALA stock results show that Kala Bio beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 06, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO Announces $12,500,000 Private Placement
June 27, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
Kala Bio: Q3 Earnings Insights
November 13, 2023
Via
Benzinga
Kala Pharmaceuticals: Q1 Earnings Insights
May 09, 2023
Kala Pharmaceuticals (NASDAQ:KALA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Where Kala Pharmaceuticals Stands With Analysts
May 01, 2023
Via
Benzinga
KALA BIO to Present at Jefferies Global Healthcare Conference
May 29, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA Stock Earnings: Kala Pharmaceuticals Misses EPS for Q1 2024
May 14, 2024
KALA stock results show that Kala Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 14, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA Stock Earnings: Kala Pharmaceuticals Beats EPS for Q4 2023
April 02, 2024
KALA stock results show that Kala Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 29, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
February 26, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 06, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 19, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 05, 2023
Via
Benzinga
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 13, 2023
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 20, 2023
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 04, 2023
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Participate in Upcoming Investor Conferences in August
August 02, 2023
From
KALA BIO, Inc.
Via
GlobeNewswire
Kala Pharmaceuticals Announces Name Change to KALA BIO
August 02, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
10 Short Squeeze Stocks To Watch: Aeglea Biotherapeutics, Toro Corp, AirSculpt, A Company Moves Up 4,166 Positions & More
July 24, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...
Via
Benzinga
Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 19, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 23, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
June 02, 2023
Via
Benzinga
Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference
June 02, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
10 Short Squeeze Stocks To Watch: Toro Corp, PaxMedica, Getty Images And More
May 15, 2023
Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High-short interest and high-cost to borrow are among the...
Via
Benzinga
Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 09, 2023
From
Kala Pharmaceuticals, Inc.
Via
GlobeNewswire
5 Short Squeeze Stocks To Watch: Getty Images, Bullfrog AI And A New Leader For The Week
May 08, 2023
Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High short interest and high cost to borrow are among the...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.